BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 32828969)

  • 21. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
    Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
    Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA NEAT1: Key player in neurodegenerative diseases.
    Li K; Wang Z
    Ageing Res Rev; 2023 Apr; 86():101878. PubMed ID: 36738893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease.
    Onyango I; Khan S; Miller B; Swerdlow R; Trimmer P; Bennett P
    J Alzheimers Dis; 2006 Jul; 9(2):183-93. PubMed ID: 16873965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of connexins in neurodegenerative diseases (Review).
    Xing J; Xu C
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
    Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
    Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
    Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current data on the pathogenesis of neurodegenerative diseases and some muscular disorders: therapeutic prospectives].
    Vécsei L; Pál E
    Orv Hetil; 1993 Aug; 134(31):1683-7. PubMed ID: 8341549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Mitochondrial Copy Number in Neurodegenerative Diseases: Present Insights and Future Directions.
    Cerantonio A; Citrigno L; Greco BM; De Benedittis S; Passarino G; Maletta R; Qualtieri A; Montesanto A; Spadafora P; Cavalcanti F
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of mtDNA disturbances in the pathogenesis of Alzheimer's and Parkinson's disease.
    Antonyová V; Kejík Z; Brogyányi T; Kaplánek R; Pajková M; Talianová V; Hromádka R; Masařík M; Sýkora D; Mikšátková L; Martásek P; Jakubek M
    DNA Repair (Amst); 2020; 91-92():102871. PubMed ID: 32502755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondria, oxidative stress and neurodegeneration.
    Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
    J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive performance in healthy clinical trial participants and patients with the NeuroCart, a neurodegenerative disease measured with an automated neuropsychological and neurophysiological test battery.
    Prins S; Borghans L; de Kam ML; Groeneveld GJ; van Gerven J
    J Neurol Sci; 2023 Jun; 449():120658. PubMed ID: 37079973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases.
    Saleem A; Javed M; Akhtar MF; Sharif A; Akhtar B; Naveed M; Saleem U; Baig MMFA; Zubair HM; Bin Emran T; Saleem M; Ashraf GM
    Curr Gene Ther; 2024; 24(2):122-134. PubMed ID: 37861022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
    Oliveira JM
    J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Basis of Alzheimer's Disease: Focus on Mitochondria.
    Oliver DMA; Reddy PH
    J Alzheimers Dis; 2019; 72(s1):S95-S116. PubMed ID: 30932888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.
    Ayala-Peña S
    Free Radic Biol Med; 2013 Sep; 62():102-110. PubMed ID: 23602907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.
    Nakamura T; Lipton SA
    Apoptosis; 2010 Nov; 15(11):1354-63. PubMed ID: 20177970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress and mitochondrial dysfunction in neurodegeneration.
    Schapira AH
    Curr Opin Neurol; 1996 Aug; 9(4):260-4. PubMed ID: 8858182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Damage in Mitochondrial DNA Associated with Parkinson's Disease.
    Martín-Jiménez R; Lurette O; Hebert-Chatelain E
    DNA Cell Biol; 2020 Aug; 39(8):1421-1430. PubMed ID: 32397749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.